These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 19183238

  • 1. Docking, virtual high throughput screening and in silico fragment-based drug design.
    Zoete V, Grosdidier A, Michielin O.
    J Cell Mol Med; 2009 Feb; 13(2):238-48. PubMed ID: 19183238
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Theoretical and practical considerations in virtual screening: a beaten field?
    Kontoyianni M, Madhav P, Suchanek E, Seibel W.
    Curr Med Chem; 2008 Feb; 15(2):107-16. PubMed ID: 18220766
    [Abstract] [Full Text] [Related]

  • 4. Ligand docking and structure-based virtual screening in drug discovery.
    Cavasotto CN, Orry AJ.
    Curr Top Med Chem; 2007 Feb; 7(10):1006-14. PubMed ID: 17508934
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In silico prediction of SARS protease inhibitors by virtual high throughput screening.
    Plewczynski D, Hoffmann M, von Grotthuss M, Ginalski K, Rychewski L.
    Chem Biol Drug Des; 2007 Apr; 69(4):269-79. PubMed ID: 17461975
    [Abstract] [Full Text] [Related]

  • 7. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD.
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Virtual screening strategies in drug discovery.
    McInnes C.
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates.
    Kirchmair J, Distinto S, Schuster D, Spitzer G, Langer T, Wolber G.
    Curr Med Chem; 2008 Oct; 15(20):2040-53. PubMed ID: 18691055
    [Abstract] [Full Text] [Related]

  • 12. Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.
    Vucicevic J, Nikolic K, Mitchell JBO.
    Curr Med Chem; 2019 Oct; 26(21):3874-3889. PubMed ID: 28707592
    [Abstract] [Full Text] [Related]

  • 13. Virtual Ligand Screening Using PL-PatchSurfer2, a Molecular Surface-Based Protein-Ligand Docking Method.
    Shin WH, Kihara D.
    Methods Mol Biol; 2018 Oct; 1762():105-121. PubMed ID: 29594770
    [Abstract] [Full Text] [Related]

  • 14. DEKOIS: demanding evaluation kits for objective in silico screening--a versatile tool for benchmarking docking programs and scoring functions.
    Vogel SM, Bauer MR, Boeckler FM.
    J Chem Inf Model; 2011 Oct 24; 51(10):2650-65. PubMed ID: 21774552
    [Abstract] [Full Text] [Related]

  • 15. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.
    Pozzan A.
    Curr Pharm Des; 2006 Oct 24; 12(17):2099-110. PubMed ID: 16796558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
    Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ.
    Nat Protoc; 2016 May 24; 11(5):905-19. PubMed ID: 27077332
    [Abstract] [Full Text] [Related]

  • 18. Computational resources for protein modelling and drug discovery applications.
    Dhaliwal B, Chen YW.
    Infect Disord Drug Targets; 2009 Nov 24; 9(5):557-62. PubMed ID: 19594423
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.